|
TIME
|
PROGRAM DETAIL
|
||
|---|---|---|---|
|
09:30 - 11:05
|
Scientific Session 4.1 Topic: Antivirals
Chairs: Bruno Canard, CNRS - Aix Marseille University (FR) Stefan Pöhlmann, German Primate Center - Leibniz Institute for Primate Research (DE) |
||
|
09:30 - 09:55
|
Invited speaker talk
Discovery and Development of Coronaviral Inhibitors targeting Viral Methyltransferases Deyin Guo, Guangzhou National Laboratory (CN) |
||
|
09:55-10:10
|
Allosteric Control of SARS-CoV-2 Exoribonuclease and Resistance to Nucleotide Analog-Based Antivirals
Chang Liu, The Johns Hopkins University School of Medicine (US) |
||
|
10:10-10:25
|
An ultrapotent bispecific nanobody delivered intranasally blocks contact transmission of SARS-CoV-1/2 and therapeutically clears MERS-CoV
Xiaoyu Zhao, Fudan University (CN) |
||
|
10:25-10:40
|
A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformation
Huihui Mou, Boston Children's Hospital, Harvard Medical School (US) |
||
|
10:41-10:48
|
A Novel Host-Targeted Antiviral Inhibiting Glycerophospholipid Metabolism in Feline Infectious Peritonitis Virus Infection
Guoqian GU, City University of Hong Kong (CN) |
||
|
10:49-10:56
|
Intranasal administration of a broadly neutralising macrocyclic peptide inhibitor protects against SARS-CoV-2 infection
Daniel Hurdiss, Utrecht University (NL) |
||
|
10:56-11:05
|
Pan-coronavirus antiviral drug discovery driven by proteomic and gene expression analysis in alveolar type II cells
Jessica Neil, The University of Melbourne (AU) |
||
|
11:05 - 11:25
|
Break
|
||
|
11:25 - 13:10
|
Scientific Session 4.2 Topic: Zoonotic transmission
Chair: Linda Saif, The Ohio State University (US) Leo Poon, University of Hong Kong (CN) Ying Fang, University of Illinois at Urbana-Champaign (US) |
||
|
11:25-11:50
|
Invited speaker talk
Viral recombination as a multiscale pathway of conditional constraints Simon John Anthony, University of California Davis (US) |
||
|
11:50-12:05
|
Species-specific expression of ACE2 in multiciliated airway cells determines SARS-CoV-2 susceptibility
Tim Breugem, Erasmus MC (NL) |
||
|
12:05-12:20
|
Animal Organoids to Study Zoonotic Coronaviruses
Alexandre Bouffier, Erasmus Medical Center (NL) |
||
|
12:20-12:35
|
Clade C MERS-CoV camel strains vary in protease usage during viral entry and interferon antagonism
Helena Winstone, University of Pennsylvania (US) |
||
|
12:35-12:50
|
Experimental SARS-CoV-2 infection using horseshoe bats
Kaoru Usui, The University of Tokyo (JP) |
||
|
12:50-13:05
|
Incidence, Genomic, and Phenotypic Characterization of Recent MERS-CoV Strains in East Africa
Marcel Müller, Charité - Universitätsmedizin Berlin (DE) |
||
|
13:05-13:10
|
Flash Talk and Discussions
Evolution of receptor usage plasticity in merbecoviruses through a computational approach Jarel Elgin Tolentino, The University of Tokyo (JP) |
||
|
13:10-13:15
|
Closing Remarks by Co-Chairpersons
|
||
